No abstract available
MeSH terms
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antineoplastic Agents / therapeutic use*
-
Boron Compounds / therapeutic use
-
Bortezomib / therapeutic use
-
Bridged Bicyclo Compounds, Heterocyclic
-
Clinical Trials as Topic*
-
Cyclic N-Oxides
-
Drug Approval
-
Drug Discovery
-
Glycine / analogs & derivatives
-
Glycine / therapeutic use
-
Humans
-
Indolizines
-
Lactones / therapeutic use
-
Lenalidomide
-
Multiple Myeloma / drug therapy*
-
Oligopeptides / therapeutic use
-
Practice Guidelines as Topic
-
Pyridinium Compounds
-
Pyrroles / therapeutic use
-
Thalidomide / analogs & derivatives
-
Thalidomide / therapeutic use
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Boron Compounds
-
Bridged Bicyclo Compounds, Heterocyclic
-
Cyclic N-Oxides
-
Indolizines
-
Lactones
-
ONX 0912
-
Oligopeptides
-
Pyridinium Compounds
-
Pyrroles
-
elotuzumab
-
dinaciclib
-
daratumumab
-
Thalidomide
-
Bortezomib
-
marizomib
-
ixazomib
-
Lenalidomide
-
Glycine